Atopic Dermatitis

FDA grants delgocitinib fast track designation for chronic hand eczema
August 05, 2020

The U.S. Food and Drug Administration (FDA) has granted JAK-inhibitor delgocitinib cream (LEO Pharma) Fast Track Designation for chronic hand eczema.

Experts discuss pediatric atopic dermatitis treatments
July 24, 2020

Gain insight from the experts on current and future treatment for pediatric atopic dermatitis.

FDA accepts BLA for tralokinumab for atopic dermatitis
July 09, 2020

The U.S. Food and Drug administration has accepted the Biologics License Application for tralokinumab (LEO Pharma) for moderate-to-severe atopic dermatitis and is expected to make a decision in the second quarter of 2021.